Disease & disorder
GM2 gangliosidosis, dog
MONDO:1012602
A lysosomal storage disease that occurs in dogs in which there is a buildup of GM2 gangliosides in tissues due to the lack of the enzyme hexosaminidase. It is characterised by progressive neuromuscular dysfunction and impaired growth from an early age.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.